Teva Pharmaceutical Industries Limited (TLV:TEVA)
6,584.00
+17.00 (0.26%)
Sep 11, 2025, 5:27 PM IDT
TLV:TEVA Revenue
Teva Pharmaceutical Industries had revenue of $4.18B USD in the quarter ending June 30, 2025, with 0.29% growth. This brings the company's revenue in the last twelve months to $16.63B, up 2.07% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.
Revenue (ttm)
$16.63B
Revenue Growth
+2.07%
P/S Ratio
1.36
Revenue / Employee
$465.95K
Employees
35,686
Market Cap
76.30B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.54B | 698.00M | 4.40% |
Dec 31, 2023 | 15.85B | 921.00M | 6.17% |
Dec 31, 2022 | 14.93B | -953.00M | -6.00% |
Dec 31, 2021 | 15.88B | -781.00M | -4.69% |
Dec 31, 2020 | 16.66B | -228.00M | -1.35% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Danel (Adir Yeoshua) | 2.84B |
Kamada | 571.15M |
BrainsWay | 155.27M |
Bait Bakfar | 106.25M |
SofWave Medical | 234.12M |
Novolog (Pharm-Up 1966) | 2.04B |
Ilex Medical | 922.54M |
InterCure | 238.85M |
Teva Pharmaceutical Industries News
- 3 days ago - Insider Buying: David Mcavoy Acquires Shares in Teva Pharmaceutical Industries Ltd (TEVA) - GuruFocus
- 4 days ago - Teva Pharmaceutical Industries Limited (TEVA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 days ago - TEVA Secures FDA Fast Track for Emrusolmin in MSA Treatment - GuruFocus
- 4 days ago - Teva gets FDA fast track status for multiple system atrophy drug - Seeking Alpha
- 4 days ago - Teva Pharmaceuticals (TEVA) Gains FDA Fast Track for MSA Treatment - GuruFocus
- 4 days ago - Teva Pharmaceutical Industries Ltd (TEVA) Receives FDA Fast Track Designation for Emrusolmin in ... - GuruFocus
- 7 days ago - Colorado must face Teva's lawsuit over free allergy pen law - Reuters
- 10 days ago - Teva Pharmaceutical Industries Ltd (TEVA) Announces CEO Presentations at Upcoming Investor ... - GuruFocus